bd 1047 has been researched along with Memory Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alkam, T; Espallergues, J; Keller, E; Maurice, T; Nabeshima, T; Nitta, A; Vamvakides, A; Villard, V; Yamada, K | 1 |
1 other study(ies) available for bd 1047 and Memory Disorders
Article | Year |
---|---|
Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice.
Topics: Amyloid beta-Peptides; Animals; Avoidance Learning; Brain; Caspase 3; Caspase 9; Cell Death; Ethylenediamines; Furans; Glial Fibrillary Acidic Protein; Hippocampus; Learning Disabilities; Lipid Peroxidation; Male; Memory; Memory Disorders; Mice; Muscarinic Antagonists; Neuroimmunomodulation; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Scopolamine; Space Perception | 2009 |